Загрузка...
The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users
AIMS: Activation of PPARγ by pioglitazone (PIO) has shown some efficacy in attenuating addictive-like responses in laboratory animals. The ability of PIO to alter the effects of opioids in humans has not been characterized in a controlled laboratory setting. The proposed investigation sought to exam...
Сохранить в:
| Опубликовано в: : | Physiol Behav |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5444321/ https://ncbi.nlm.nih.gov/pubmed/26455893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.physbeh.2015.10.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|